Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Lymphoma: pre-treatment PET scans

Paolo Strati, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, highlights the key findings from a trial looking at pre-treatment PET scans of 346 patients with advanced stage fully grown lymphoma; observing that generally those with high SUVmax had a shorter overall survival rate, independent of the type of treatment used. Speaking from the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting in Chicago, IL, Dr Strati demonstrates the need to determine the prognostic value of the pre-treatment PET scans and SUVmax measurement.